Vaxart, Inc. Increase (Decrease) in Deferred Revenue
Vaxart, Inc. (VXRT) reported Increase (Decrease) in Deferred Revenue of $0 for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2024-08-08
- Vaxart, Inc. increase (decrease) in deferred revenue for the quarter ending 2024-06-30 was $0.00.
- Vaxart, Inc. increase (decrease) in deferred revenue for the quarter ending 2024-03-31 was $0.00.
- Vaxart, Inc. increase (decrease) in deferred revenue for the quarter ending 2023-12-31 was -$79.00K, a 103.95% decline year-over-year.
- Vaxart, Inc. increase (decrease) in deferred revenue for the quarter ending 2023-09-30 was -$196.00K.
- Vaxart, Inc. increase (decrease) in deferred revenue for fiscal 2023 was -$2.00M, a 200.00% decline from fiscal 2022.
- Vaxart, Inc. increase (decrease) in deferred revenue for fiscal 2022 was $2.00M.
- Vaxart, Inc. increase (decrease) in deferred revenue for fiscal 2021 was $0.00.
- Vaxart, Inc. increase (decrease) in deferred revenue for fiscal 2014 was -$300.00K.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 6 month as first filed | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 9 month as first filed | Increase (Decrease) in Deferred Revenue 12 month | Increase (Decrease) in Deferred Revenue 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | -$79.00K derived: sum of 3 quarters · filed 2024-08-08 | -$275.00K derived: sum of 4 quarters · filed 2024-08-08 | |||
| 2024-03-31 | $0.00 10-Q · filed 2024-05-13 | -$79.00K derived: sum of 2 quarters · filed 2024-05-13 | -$275.00K derived: sum of 3 quarters · filed 2024-05-13 | -$1.60M derived: sum of 4 quarters · filed 2024-08-08 | |||
| 2023-12-31 | -$79.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$275.00K derived: sum of 2 quarters · filed 2024-03-14 | -$1.60M derived: sum of 3 quarters · filed 2024-08-08 | -$2.00M 10-K · filed 2024-03-14 | |||
| 2023-09-30 | -$196.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$1.52M derived: sum of 2 quarters · filed 2024-08-08 | -$1.92M 10-Q · filed 2023-11-02 | $79.00K derived: sum of 4 quarters · filed 2024-08-08 | |||
| 2023-06-30 | -$1.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$1.73M 10-Q · filed 2024-08-08 | $275.00K derived: sum of 3 quarters · filed 2024-08-08 | $275.00K derived: sum of 4 quarters · filed 2024-08-08 | |||
| 2023-03-31 | -$397.00K 10-Q · filed 2024-05-13 | $1.60M derived: sum of 2 quarters · filed 2024-05-13 | $1.60M derived: sum of 3 quarters · filed 2024-05-13 | $1.60M derived: sum of 4 quarters · filed 2024-05-13 | |||
| 2022-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $2.00M derived: sum of 2 quarters · filed 2024-03-14 | $2.00M derived: sum of 3 quarters · filed 2024-03-14 | $2.00M 10-K · filed 2024-03-14 | -$2.00M 10-K · filed 2023-03-15 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $0.00 derived: sum of 2 quarters · filed 2023-11-02 | $0.00 10-Q · filed 2023-11-02 | ||||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $0.00 10-Q · filed 2023-08-03 | |||||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-04 | ||||||
| 2021-12-31 | $0.00 10-K · filed 2023-03-15 | ||||||
| 2014-06-30 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-13 | -$100.00K derived: sum of 2 quarters · filed 2016-09-13 | -$100.00K derived: sum of 3 quarters · filed 2016-09-13 | -$300.00K 10-K · filed 2016-09-13 | |||
| 2014-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-08 | $0.00 derived: sum of 2 quarters · filed 2015-05-08 | -$200.00K 10-Q · filed 2015-05-08 | -$500.00K derived: sum of 4 quarters · filed 2015-09-11 | |||
| 2013-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-06 | -$200.00K 10-Q · filed 2015-02-06 | -$500.00K derived: sum of 3 quarters · filed 2015-09-11 | -$700.00K derived: sum of 4 quarters · filed 2015-09-11 | |||
| 2013-09-30 | -$200.00K 10-Q · filed 2014-11-07 | -$500.00K derived: sum of 2 quarters · filed 2015-09-11 | -$700.00K derived: sum of 3 quarters · filed 2015-09-11 | -$200.00K derived: sum of 4 quarters · filed 2015-09-11 | |||
| 2013-06-30 | -$300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-11 | -$500.00K derived: sum of 2 quarters · filed 2015-09-11 | $0.00 derived: sum of 3 quarters · filed 2015-09-11 | -$100.00K 10-K · filed 2015-09-11 | |||
| 2013-03-31 | -$200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-12 | $300.00K derived: sum of 2 quarters · filed 2014-05-12 | $200.00K 10-Q · filed 2014-05-12 | $237.00K 10-Q · filed 2013-05-10 | -$431.00K derived: sum of 4 quarters · filed 2014-05-12 | ||
| 2012-12-31 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-10 | $400.00K 10-Q · filed 2014-02-10 | $485.00K 10-Q · filed 2013-02-11 | -$231.00K derived: sum of 3 quarters · filed 2014-02-10 | -$863.00K derived: sum of 4 quarters · filed 2014-02-10 | ||
| 2012-09-30 | -$100.00K 10-Q · filed 2013-11-12 | -$731.00K derived: sum of 2 quarters · filed 2013-11-12 | -$1.90M 10-Q · filed 2012-11-08 | -$2.00M derived: sum of 4 quarters · filed 2013-11-12 | |||
| 2012-06-30 | -$631.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$1.26M 10-Q · filed 2012-08-09 | -$1.90M derived: sum of 3 quarters · filed 2012-08-09 | $200.00K 10-K · filed 2014-09-30 | |||
| 2012-03-31 | -$632.00K 10-Q · filed 2012-05-10 | -$1.26M derived: sum of 2 quarters · filed 2012-05-10 | $255.00K 10-Q · filed 2013-05-10 | -$5.16M derived: sum of 4 quarters · filed 2012-08-09 | |||
| 2011-12-31 | -$632.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-14 | $353.00K 10-Q · filed 2013-02-11 | -$4.53M derived: sum of 3 quarters · filed 2012-08-09 | -$7.80M 10-K · filed 2012-03-14 | |||
| 2011-09-24 | -$631.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | -$3.90M derived: sum of 2 quarters · filed 2012-08-09 | -$7.17M 10-Q · filed 2012-11-08 | -$10.43M derived: sum of 4 quarters · filed 2012-08-09 | |||
| 2011-06-30 | -$2.40M 10-K · filed 2013-09-27 | ||||||
| 2011-06-25 | -$3.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$6.53M 10-Q · filed 2012-08-09 | -$9.80M derived: sum of 3 quarters · filed 2012-08-09 | -$13.07M derived: sum of 4 quarters · filed 2012-08-09 | |||
| 2011-03-26 | -$3.27M 10-Q · filed 2012-05-10 | -$6.53M derived: sum of 2 quarters · filed 2012-05-10 | -$9.80M derived: sum of 3 quarters · filed 2012-05-10 | ||||
| 2010-12-25 | -$3.27M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-14 | -$6.53M derived: sum of 2 quarters · filed 2012-03-14 | $24.72M 10-K · filed 2012-03-14 | ||||
| 2010-09-25 | -$3.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $27.98M 10-Q · filed 2011-11-02 | |||||
| 2010-06-26 | $31.25M 10-Q · filed 2011-08-03 | ||||||
| 2009-12-26 | $18.45M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |